Archive - November 2019
FDA backs GBT’s sickle cell drug Oxbryta
Teva among generic drugmakers hoping to settle US antitrust probe
Private equity firm backs Ferring gene therapy venture
NHS has ‘big tech’ patient data analysis fears
Pooled bempedoic acid data shows success in cholesterol, haemoglobin
Mavenclad granted accelerated access by NICE
Healx backs Rare Treatment Accelerator with $20m
EEE Outbreak 2019: Should We Be Worried?